Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Rutgers researchers create new device to see if targeted cancer therapy is working

Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients.

17 Jul 2019

AI-enabled device detects if targeted chemotherapy is working

A new portable device that utilizes artificial intelligence (AI) and biosensors can rapidly detect if cancer cells thrive after chemotherapy treatment.

17 Jul 2019

Engineered stem cells offer new treatment for metastatic bone cancer

Engineered stem cells could help treat metastatic cancers in bone without killing normal surrounding bone.

9 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Have cancer, must travel: Patients left in lurch after hospital closes

One Monday in February, 65-year-old Karen Endicott-Coyan gripped the wheel of her black 2014 Ford Taurus with both hands as she made the hour-long drive from her farm near Fort Scott to Chanute.

1 Jul 2019

Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in Journal of Clinical Oncology.

14 Jun 2019

Roswell Park physician leads effort to compile new multiple myeloma imaging guidelines

Just as newer drugs have significantly improved outcomes for patients with multiple myeloma in the past decade, newer imaging techniques are upgrading detection of the disease, leading to earlier treatment.

14 Jun 2019

Drug therapy may delay onset of myeloma symptoms, finds study

The largest randomized trial involving smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of myeloma symptoms, according to Mayo Clinic researchers.

3 Jun 2019

Finding potential treatments for autoimmune diseases

More than 50 million Americans are affected by an autoimmune disease, with women at an increased risk for developing one.

7 May 2019

DNA rearrangement may predict poor outcomes in multiple myeloma

A certain type of DNA marker predicts poor outcomes in multiple myeloma, researchers at Winship Cancer Institute, Emory University have found.

24 Apr 2019

Different types of myeloma need specific criteria diagnostic criteria

When our plasma cells start producing a single cancer-causing protein rather than an array of antibody-like proteins to protect us, it's one of two arms of the Y-shaped protein that's likely to blame.

8 Apr 2019

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

Although the majority of patients who have blood cancers are older adults, they make up only a small percentage of participants in the clinical trials that lead to new therapies.

8 Apr 2019

Researchers define pathway that helps us make antibodies

Our bodies are continuously concocting specific antibodies to thwart invaders like a virus or even pollen, and scientists have new information about how the essential production gets fired up and keeps up.

13 Mar 2019

Biophysicists visualize atomic-level dynamics of largest protein-degrading machine

Protein dynamics are essential for their functions. Protein nanomachines made of multiple protein molecules are highly dynamics during their actions on their functional targets, sometime called substrates.

26 Feb 2019

New research finds how cancer cells acquire resistance to molecular-targeted drugs

Although molecular-targeted drugs have been known to show high efficacy to lung cancer patients, they also have limitations due to acquiring resistance to the drug used.

25 Feb 2019

Intense exercise, fasting and hormones can enhance waste-protein removal, study shows

The body's ability to adapt to changing conditions and shifting physiologic demands is essential to survival. To do so, each cell must be able to dispose of damaged or unnecessary proteins--a quality-control mechanism critical for cellular performance and for the health of the entire organism.

21 Feb 2019

MUSC researchers discover new mechanism for a class of anti-cancer drugs

Researchers at the Medical University of South Carolina reveal a novel binding site for a class of anti-cancer drugs known as E1 inhibitors. This finding could lead to the design of more efficient E1 inhibitors.

15 Feb 2019

New bioengineered device enhances the production of T-cells

Bone marrow transplants, also known as hematopoietic stem cell transplants, are life-saving treatments for aggressive diseases, such as leukemia and multiple myeloma, and infections such as HIV. The procedure entails infusion of blood stem cells from a matched donor into the patient to 'reset' the blood and immune system.

12 Feb 2019

AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma

AbbVie, Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that they have entered a global strategic transaction to develop and commercialize TNB-383B, a BCMA-targeting immunotherapeutic for the potential treatment of multiple myeloma.

12 Feb 2019

Obesity-related cancers are rising rapidly among adolescents in the US

A new study has found that the incidence of obesity-related cancers in the US is rising faster among millennials than it is among older age groups.

4 Feb 2019

Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Rutgers researchers create new device to see if targeted cancer therapy is working

AI-enabled device detects if targeted chemotherapy is working

Engineered stem cells offer new treatment for metastatic bone cancer

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Have cancer, must travel: Patients left in lurch after hospital closes

Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

Roswell Park physician leads effort to compile new multiple myeloma imaging guidelines

Drug therapy may delay onset of myeloma symptoms, finds study

Finding potential treatments for autoimmune diseases

DNA rearrangement may predict poor outcomes in multiple myeloma

Different types of myeloma need specific criteria diagnostic criteria

ASCO issues guideline recommending older adults with cancer to receive geriatric assessment

Researchers define pathway that helps us make antibodies

Biophysicists visualize atomic-level dynamics of largest protein-degrading machine

New research finds how cancer cells acquire resistance to molecular-targeted drugs

Intense exercise, fasting and hormones can enhance waste-protein removal, study shows

MUSC researchers discover new mechanism for a class of anti-cancer drugs

New bioengineered device enhances the production of T-cells

AbbVie, Teneobio enter into strategic transaction to develop potential treatment for multiple myeloma

Obesity-related cancers are rising rapidly among adolescents in the US

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in